Contract Research Organization WCCT Global Announces Clinical Study Rescue Plan Due to a Recent Closure of a Large CRO

Share Article

WCCT Global focuses energy on implementing a clinical study rescue plan to expedite the start up of clinical studies that were affected by recent closure of a large CRO.

Rescue Clinical Trials
we know the importance of being able to scale quickly and assess the availability of existing study data to determine the exact ’level’ of rescue needed.

WCCT Global, a contract research organization headquartered in Southern California, announced today that due to the recent closing of a large CRO, WCCT Global has established a plan to complete clinical trials that may have been not finished at the closed site. VP of Business Development, Talia Nikolao stated, “Putting together a program-specific rescue plan is extremely important. WCCT has successfully rescued several programs in the last two years, and we know the importance of being able to scale quickly and assess the availability of existing study data to determine the exact ’level’ of rescue needed. We have a strategy to assess programs, make recommendations to Sponsors, and collaborate throughout to ensure successful transition of the programs with as minimal negative impact as possible.”

When implementing a clinical program rescue plan, WCCT Global reviews every element of the program to see exactly what data is missing from the trial(s), and then makes a custom plan of action to expedite the completion of the program. This plan can be implemented for any/all trials across a variety of therapeutic areas. This new plan allows WCCT Global to prioritize the rescue effort and respond quickly to Sponsor’s needs.

More information about WCCT Global:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to see how WCCT Global can apply the Clinical Study Rescue Plan for your organization, CLICK HERE and tell us about the study.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Talia A. Nikolao, M.B.A.
WCCT Global, LLC
1.714.252.0700 2201
Email >
Follow us on
Visit website